Long Non-Coding RNA Myosin Light Chain Kinase Antisense 1 Plays an Oncogenic Role in Gallbladder Carcinoma by Promoting Chemoresistance and Proliferation-Reference-Cited by-同舟云学术

Long Non-Coding RNA Myosin Light Chain Kinase Antisense 1 Plays an Oncogenic Role in Gallbladder Carcinoma by Promoting Chemoresistance and Proliferation

Published:2021-08 Issue: Volume:Volume 13 Page:6219-6230
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Li Yongliang,Tian Mi,Zhang Dongqing,Zhuang Yifei,Li Zhimin,Xie Shenqi,Sun Keyu

Publisher

Informa UK Limited

Subject

Oncology

Reference31 articles.

1. Loss of desmoglein-2 promotes gallbladder carcinoma progression and resistance to EGFR-targeted therapy through Src kinase activation

2. Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer

3. On the classification of long non-coding RNAs

4. Non-coding RNA networks in cancer

5. The lncRNA SCARNA2 mediates colorectal cancer chemoresistance through a conserved microRNA‐342‐3p target sequence

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural products and long noncoding RNA signatures in gallbladder cancer: a review focuses on pathogenesis, diagnosis, and drug resistance;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-07-19

2. EZH2: A Critical Competing Endogenous RNA in Cancer Research - A Scoping Review;2024-04-22

3. Long non‑coding RNAs in gallbladder cancer: From mechanisms to therapeutic opportunities (Review);International Journal of Oncology;2023-12-14

4. Drug resistance and new therapies in gallbladder cancer;Drug Discoveries & Therapeutics;2023-08-31

5. Update on Chemoresistance Mechanisms to First-Line Chemotherapy for Gallbladder Cancer and Potential Reversal Strategies;American Journal of Clinical Oncology;2023-03-03